dc.contributor.author | Seaton, Terry L. | eng |
dc.contributor.author | Meadows, Susan E. | eng |
dc.date.issued | 2002 | eng |
dc.description.abstract | The levels of cholesterol that should be treated for primary prevention are based on low-density lipoprotein cholesterol (LDL-C) levels of > 100 mg/dL to > 190 mg/dL and vary according to whether the patient's risk is high, moderate, or low. See the table to estimate risk. Grade of recommendation for medication indications: A (on the basis of high-quality randomized controlled trials). Grade of recommendation for lifestyle indications: B (on the basis of extrapolations from randomized controlled trials). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/2870 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2002 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 51, no. 05 (May 2002): 423. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | cardiovascular risk | eng |
dc.subject.lcsh | Lipoproteins | eng |
dc.subject.lcsh | Statins (Cardiovascular agents) | eng |
dc.subject.lcsh | Low density lipoproteins | eng |
dc.subject.lcsh | Lipids | eng |
dc.subject.lcsh | Cardiovascular system -- Diseases -- Risk factors | eng |
dc.subject.lcsh | Coronary heart disease | eng |
dc.title | What levels of cholesterol should be treated for primary prevention? | eng |
dc.type | Article | eng |